The Translational Initiative to Map Epigenetics in Aging (TIME-A)

NCT05760547 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 25000

Last updated 2023-03-08

No results posted yet for this study

Summary

The Translational Initiative to Map Epigenetics in Aging (TIME-A) study aims to advance our understanding of the connections between epigenetics, lifestyle, demographics, and health and aging.

Conditions

  • Biological Aging

Sponsors & Collaborators

  • Elysium Health

    lead INDUSTRY

Principal Investigators

  • Dayle Sampson, PhD · Elysium Health

  • Holly Holmes, PhD · Elysium Health

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-03-08
Primary Completion
2033-03-31
Completion
2033-03-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05760547 on ClinicalTrials.gov